Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk [Seeking Alpha]
Dynavax Technologies Corporation (DVAX)
Last dynavax technologies corporation earnings: 3/11 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.dynavax.com
Company Research
Source: Seeking Alpha
SNY strengthens its adult vaccine portfolio with HEPLISAV-B, a commercial hepatitis B vaccine, and gains a long-term option on DVAX's shingles candidate. The acquisition is low-risk, funded from SNY's cash reserves, with no impact on 2025 guidance; SNY maintains a Buy rating, DVAX a Hold. DVAX shareholders receive a ~39% premium, but upside from pipeline assets like Z 1018 now shifts to SNY; no meaningful arbitrage remains. aerogondo/iStock via Getty Images Overview Dynavax ( DVAX ) is joining forces with Sanofi ( SNY ) this Festivus season! Revealed on Christmas Eve, Sanofi will acquire Dynavax for $15.50 per share in cash via a tender offer. This values Dynavax at ~$2.2 billion This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving
Show less
Read more
Impact Snapshot
Event Time:
DVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DVAX alerts
High impacting Dynavax Technologies Corporation news events
Weekly update
A roundup of the hottest topics
DVAX
News
- Press release: 2025: strong sales and EPS growth. Continued profitable growth expected in 2026 [Yahoo! Finance]Yahoo! Finance
- Dynavax gains on disclosure another bidder interested after deal announced [Seeking Alpha]Seeking Alpha
- Is It Time To Reassess Dynavax Technologies (DVAX) After Its Recent Share Price Surge [Yahoo! Finance]Yahoo! Finance
- Lightning Round: Buy some Talen Energy here, says Jim Cramer [CNBC]CNBC
- Halper Sadeh LLC Encourages DVAX, FONR, DBRG, ONTF Shareholders to Contact the Firm to Discuss Their RightsGlobeNewswire
DVAX
Earnings
- 11/5/25 - Beat
DVAX
Sec Filings
- 2/2/26 - Form SC
- 1/30/26 - Form SC
- 1/30/26 - Form SC
- DVAX's page on the SEC website